Cathepsin-L Can Resist Lysis by Human Serum in Trypanosoma brucei brucei

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Alsford, Sam ^a   Currier, Rachel B ^a   Guerra Assunção, José Afonso ^a   Clark, Taane G ^a   Horn, David ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; CATHEPSIN L; PLASMA PROTEIN;

AFRICAN TRYPANOSOMIASIS; BLOOD; CELL CULTURE; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; TRANSGENIC ORGANISM; TRYPANOSOMA BRUCEI BRUCEI;

BLOOD PROTEINS; CATHEPSIN L; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; ORGANISMS, GENETICALLY MODIFIED; PROTEOLYSIS; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84901676974     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004130     Document Type: Article

References (50)

1. Vanhollebeke B, Pays E, (2010) The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol Microbiol 76: 806-814.
2. Stephens NA, Hajduk SL, (2011) Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity. Eukaryot Cell 10: 1023-1033.
3. Jackson AP, Sanders M, Berry A, McQuillan J, Aslett MA, et al. (2010) The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis. PLoS Negl Trop Dis 4: e658.
4. Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG, (2011) The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop Dis 5: e1007.
5. Hajduk SL, Moore DR, Vasudevacharya J, Siqueira H, Torri AF, et al. (1989) Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J Biol Chem 264: 5210-5217.
6. Rifkin MR, (1978) Identification of the trypanocidal factor in normal human serum: high density lipoprotein. Proc Natl Acad Sci U S A 75: 3450-3454.
7. Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S, (1999) Characterization of a novel trypanosome lytic factor from human serum. Infect Immun 67: 1910-1916.
8. Tomlinson S, Jansen AM, Koudinov A, Ghiso JA, Choi-Miura NH, et al. (1995) High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum. Mol Biochem Parasitol 70: 131-138.
9. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, et al. (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422: 83-87.
10. Bullard W, Kieft R, Capewell P, Veitch NJ, Macleod A, et al. (2012) Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors. Virulence 3: 72-76.
11. Vanhollebeke B, De Muylder G, Nielsen MJ, Pays A, Tebabi P, et al. (2008) A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320: 677-681.
12. Molina-Portela MP, Lugli EB, Recio-Pinto E, Raper J, (2005) Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes. Mol Biochem Parasitol 144: 218-226.
13. Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, et al. (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309: 469-472.
14. Kieft R, Capewell P, Turner CM, Veitch NJ, MacLeod A, et al. (2010) Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc Natl Acad Sci U S A 107: 16137-16141.
15. DeJesus E, Kieft R, Albright B, Stephens NA, Hajduk SL, (2013) A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding. PLoS Pathog 9: e1003317.
16. Symula RE, Beadell JS, Sistrom M, Agbebakun K, Balmer O, et al. (2012) Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance. PLoS Negl Trop Dis 6: e1728.
17. Xong HV, Vanhamme L, Chamekh M, Chimfwembe CE, Van Den Abbeele J, et al. (1998) A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95: 839-846.
18. Capewell P, Clucas C, Dejesus E, Kieft R, Hajduk S, et al. (2013) The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog 9: e1003686.
19. Uzureau P, Uzureau S, Lecordier L, Fontaine F, Tebabi P, et al. (2013) Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature 501: 430-4.
20. Peck RF, Shiflett AM, Schwartz KJ, McCann A, Hajduk SL, et al. (2008) The LAMP-like protein p67 plays an essential role in the lysosome of African trypanosomes. Mol Microbiol 68: 933-946.
21. Hager KM, Pierce MA, Moore DR, Tytler EM, Esko JD, et al. (1994) Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes. J Cell Biol 126: 155-167.
22. Capewell P, Veitch NJ, Turner CM, Raper J, Berriman M, et al. (2011) Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1. PLoS Negl Trop Dis 5: e1287.
23. Berberof M, Perez-Morga D, Pays E, (2001) A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense. Mol Biochem Parasitol 113: 127-138.
24. Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, et al. (2011) High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Res 21: 915-924.
25. Alsford S, Eckert S, Baker N, Glover L, Sanchez-Flores A, et al. (2012) High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 482: 232-236.
26. Sanderson SJ, Westrop GD, Scharfstein J, Mottram JC, Coombs GH, (2003) Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens. FEBS Lett 542: 12-16.
27. Alphey MS, Hunter WN, (2006) High-resolution complex of papain with remnants of a cysteine protease inhibitor derived from Trypanosoma brucei. Acta Crystallogr Sect F Struct Biol Cryst Commun 62: 504-508.
28. Santos CC, Coombs GH, Lima AP, Mottram JC, (2007) Role of the Trypanosoma brucei natural cysteine peptidase inhibitor ICP in differentiation and virulence. Mol Microbiol 66: 991-1002.
29. Steverding D, Sexton DW, Wang X, Gehrke SS, Wagner GK, et al. (2012) Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target. Int J Parasitol 42: 481-488.
30. Caffrey CR, Hansell E, Lucas KD, Brinen LS, Alvarez Hernandez A, et al. (2001) Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol Biochem Parasitol 118: 61-73.
31. Mackey ZB, O'Brien TC, Greenbaum DC, Blank RB, McKerrow JH, (2004) A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. J Biol Chem 279: 48426-48433.
32. O'Brien TC, Mackey ZB, Fetter RD, Choe Y, O'Donoghue AJ, et al. (2008) A parasite cysteine protease is key to host protein degradation and iron acquisition. J Biol Chem 283: 28934-28943.
33. Alsford S, Kawahara T, Glover L, Horn D, (2005) Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects. Mol Biochem Parasitol 144: 142-148.
34. Ettari R, Tamborini L, Angelo IC, Micale N, Pinto A, et al. (2013) Inhibition of Rhodesain as a Novel Therapeutic Modality for Human African Trypanosomiasis. J Med Chem 56: 5637-58.
35. Thomson R, Molina-Portela P, Mott H, Carrington M, Raper J, (2009) Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc Natl Acad Sci U S A 106: 19509-19514.
36. Nkemgu NJ, Grande R, Hansell E, McKerrow JH, Caffrey CR, et al. (2003) Improved trypanocidal activities of cathepsin L inhibitors. Int J Antimicrob Agents 22: 155-159.
37. Shimamura M, Hager KM, Hajduk SL, (2001) The lysosomal targeting and intracellular metabolism of trypanosome lytic factor by Trypanosoma brucei brucei. Mol Biochem Parasitol 115: 227-237.
38. Redecke L, Nass K, DePonte DP, White TA, Rehders D, et al. (2013) Natively inhibited Trypanosoma brucei cathepsin B structure determined by using an X-ray laser. Science 339: 227-230.
39. Jacobs RT, Nare B, Phillips MA, (2011) State of the art in African trypanosome drug discovery. Curr Top Med Chem 11: 1255-1274.
40. Gibson W, Nemetschke L, Ndung'u J, (2010) Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense. Infect Genet Evol 10: 453-458.
41. Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R, (1997) The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop 68: 139-147.
42. Singh PK, Tack BF, McCray PB Jr, Welsh MJ, (2000) Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 279: L799-805.
43. Baker N, Alsford S, Horn D, (2011) Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. Mol Biochem Parasitol 176: 55-57.
44. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
45. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
46. Alsford S, Horn D, (2008) Single-locus targeting constructs for reliable regulated RNAi and transgene expression in Trypanosoma brucei. Mol Biochem Parasitol 161: 76-79.
47. Redmond S, Vadivelu J, Field MC, (2003) RNAit: an automated web-based tool for the selection of RNAi targets in Trypanosoma brucei. Mol Biochem Parasitol 128: 115-118.
48. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, et al. (1998) Current Protocols in Molecular Biology. New York: John Wiley and Sons, Inc.
49. Brenndorfer M, Boshart M, (2010) Selection of reference genes for mRNA quantification in Trypanosoma brucei. Mol Biochem Parasitol 172: 52-55.
50. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.